Iran News ...


12/21/04

Iran, Europe to discuss the 20 centrifuges: Iranian official

Tehran, Dec 21, IRNA -- A senior nuclear official Hossein Moussavian said in Tehran on Tuesday that the issue of the 20 centrifuges will top the agenda of the next round of Iran-EU 3 talks.

"Suspension (of uranium enrichment) was a political issue and was agreed in a political framework. It is natural that the quality of the centrifuges-related activities will be cleared in talks with the European side," added Moussavian who is the Chairman of the Foreign Policy Committee of the Supreme National Security Council.

In the next round of their talks, Iran-Europe working groups are scheduled to put to discussion the three pivotal issues of 'clear guarantee for not diverting Iran's fuel cycle, Iran-Europe peaceful nuclear cooperation and activities of the 20 centrifuges,' he said.

He stressed that Iran is for cooperation with Europe on peaceful nuclear technology and wiping off the limitations imposed on Iran during the last 25 years as well.

"We believe that the next three months is considered as the starting point to determine if the talks would be hopeful," he said commenting on his optimism about the future nuclear talks between Iran and the EU trio.

"Should the working groups provide a clear definition of the cooperation and or made agreement on the cooperation, then optimism would be possible. Otherwise, not."

He said, "This is a general decision to test the Europeans. After elapsing the three months, if the talks led to a breakthrough, we would proceed with the talks. Otherwise, we would reconsider.

"I do hope that we could get result from the talks of the working groups and put into practice the results," he said in response to the question on whether the suspension issue would be continued till mid- December next year.

... Payvand News - 12/21/04 ... --



comments powered by Disqus

Home | ArchiveContact | About |  Web Sites | Bookstore | Persian Calendar | twitter | facebook | RSS Feed


© Copyright 2004 NetNative (All Rights Reserved)